Differential Diagnosis of Parkinson’s Disease

Parkinson's Disease

Volumn , Issue , 2004, Pages 557-568

  Hung, Serena W ^a   Lang, Anthony E ^a  

^a TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33845410456     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/9780203508596-54     Document Type: Chapter

References (94)

1. Litvan, I. et al., SIC Task Force appraisal of clinical diagnostic criteria for parkinsonian disorders, Mov. Disord., 18(5), 467–486, 2003.
2. Steele, J. C., Richardson, J. C., and Olszewski, J. Progressive supranuclear palsy, Archives of Neurology, 10 333–358, 1964.
3. Cervós-Navarro, J. and Schumacher, K., Neurofibrillary pathology in progressive supranuclear palsy (PSP), J. Neural Transm., 98 Suppl., 42, 153–164, 1994.
4. Poorkaj, P. et al., An R5L tau mutation in a subject with a progressive supranuclear palsy phenotype, Ann. Neurol., 52(4), 511–516, 2002.
5. Birdi, S. et al., Progressive supranuclear palsy diagnosis and confounding features: Report on 16 autopsied cases, Movement Disorders, 17(6), 1255–1264, 2002.
6. Schrag, A., Ben-Shlomo, Y., and Quinn, N. P., Prevalence of progressive supranuclear palsy and multiple system atrophy: A cross-sectional study, Lancet, 354(9192), 1771–1775, 1999.
7. Burn, D. J. and Jaros, E., Multiple system atrophy: Cellular and molecular pathology, Journal of Clinical Pathology: Molecular Pathology, 54(6), 419–426, 2001.
8. Vodusek, D. B., Sphincter EMG and differential diagnosis of multiple system atrophy, Mov. Disord., 16(4), 600–607, 2001.
9. Sakakibara, R. et al., Urinary dysfunction and orthostatic hypotension in multiple system atrophy: Which is the more common and earlier manifestation? Journal of Neurology, Neurosurgery and Psychiatry, 68(1), 65–69, 2000.
10. Bhattacharya, K. et al., Brain magnetic resonance imaging in multiple-system atrophy and Parkinson disease —A diagnostic algorithm, Archives of Neurology, 59(5), 835–842, 2002.
11. Antonini, A. et al., Differential diagnosis of parkinsonism with [18F]fluorodeoxyglucose and PET, Movement Disorders, 13(2), 268–274, 1998.
12. Rebeiz, J. J., Kolodny, E. H., and Richardson, E. P., Corticodentatonigral degeneration with neuronal achromasia, Arch Neurol., 18, 20–33, 1968.
13. Riley, D. E. et al., Cortical-basal ganglionic degeneration, Neurology, 40:1203, 1990.
14. Watts, A. L. et al., Corticobasal degeneration, in Watts, R. L., Koller, W. C., Eds., Movement Disorders: Neurologic Principles and Practice, New York, McGraw-Hill, 611–621, 1967.
15. Vanek, Z. and Jankovic, J., Dystonia in corticobasal degeneration, Movement Disorders, 16(2), 252–257, 2001.
16. Wenning, G. K. et al., Natural history and survival of 14 patients with corticobasal degeneration confirmed at postmortem examination, Journal of Neurology, Neurosurgery and Psychiatry, 64(2), 184–189, 1998.
17. Dickson, D. W. et al., Office of Rare Diseases neuropathologic criteria for corticobasal degeneration, J. Neuropathol. Exp. Neurol., 61(11), 935–946, 2002.
18. Houlden, H. et al., Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype, Neurology, 56(12), 1702–1706, 2001.
19. Kertesz, A. et al., The corticobasal degeneration syndrome overlaps progressive aphasia and frontotemporal dementia, Neurology, 55(9), 1368–1375, 2000.
20. Hauser, R. A. et al., Magnetic resonance imaging of corticobasal degeneration, J. Neuroimaging, 6(4), 222–226, 1996.
21. Lutte, I. et al., Contribution of PET studies in diagnosis of corticobasal degeneration, European Neurology, 44(1), 12–21, 2000.
22. Weiner, M. F., Dementia associated with Lewy bodies: Dilemmas and directions, Arch. Neurol., 56(12), 1441–1442, 1999.
23. Holmes, C. et al., Validity of current clinical criteria for Alzheimer’s disease, vascular dementia and dementia with Lewy bodies, Br. J. Psychiatry, 174:45, 1999.
24. Armstrong, R. A., Cairns, N. J., and Lantos, P. L., The spatial patterns of Lewy bodies, senile plaques, and neurofibrillary tangles in dementia with Lewy bodies, Experimental Neurology, 150(1), 122–127, 1998.
25. Romano, S. and Colosimo, C., Procerus sign in progressive supranuclear palsy, Neurology, 57(10), 1928, 2001.
26. Krack, P. and Marion, M. H., “Apraxia of lid opening,” a focal eyelid dystonia: Clinical study of 32 patients, Mov. Disord., 9(6), 610–615, 1994.
27. Nath, U. et al., Clinical features and natural history of progressive supranuclear palsy: A clinical cohort study, Neurology, 60(6), 910–916, 2003.
28. Lamberti, P. et al., Frequency of apraxia of eyelid opening in the general population and in patients with extrapyramidal disorders, Neurol. Sci., 23, Suppl. 2, S81–S82, 2002.
29. Litvan, I. et al., Which clinical features differentiate progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) from related disorders? A clinicopathological study, Brain, 120(1), 65–74, 1997.
30. Litvan, I. et al., Clinical features differentiating patients with postmortem confirmed progressive supranuclear palsy and corticobasal degeneration, J. Neurol., 246, Suppl. 2, II1-II5, 1999.
31. Rascol, O. et al., Square wave jerks in parkinsonian syndromes, J. Neurol. Neurosurg. Psychiatry, 54(7), 599–602, 1991.
32. Rivaud-Pechoux, S. et al., Longitudinal ocular motor study in corticobasal degeneration and progressive supranuclear palsy, Neurology, 54(5), 1029–1032, 2000.
33. Kluin, K. J. et al., Perceptual analysis of speech disorders in progressive supranuclear palsy, Neurology, 43(3 Pt. 1), 563–566, 1993.
34. Testa, D. et al., Comparison of natural histories of progressive supranuclear palsy and multiple system atrophy, Neurol. Sci., 22(3), 247–251, 2001.
35. Yamaguchi, M. et al., Laryngeal stridor in multiple system atrophy, European Neurology, 49(3), 154–159, 2003.
36. Merlo, I. M. et al., Not paralysis, but dystonia causes stridor in multiple system atrophy, Neurology, 58(4), 649–652, 2002.
37. Giladi, N. et al., Hemiparkinsonism-hemiatrophy syndrome: Clinical and neuroradiologic features, Neurology, 40, 1731–1734, 1990.
38. Colosimo, C. et al., Some specific clinical features differentiate multiple system atrophy (striatonigral variety) from Parkinson’s disease, Archives of Neurology, 52 294–298, 1995.
39. Collins, S. J. et al., Progressive supranuclear palsy: Neuropathologically based diagnostic clinical criteria, Journal of Neurology, Neurosurgery and Psychiatry, 58, 167–173, 1995.
40. Fahn, S., Description of Parkinson’s Disease as a Clinical Syndrome, Ann. N. Y. Acad. Sci., 991, 1–14, 2003.
41. Tison, F. et al., Parkinsonism in multiple system atrophy: Natural history, severity (UPDRS-III), and disability assessment compared with Parkinson’s disease, Mov. Disord., 17(4), 701–709, 2002.
42. Masucci, E. F. and Kurtzke, J. F., Tremor in progressive supranuclear palsy, Acta Neurol. Scand., 80(4), 296–300, 1989.
43. Kompoliti, K. et al., Clinical presentation and pharmacological therapy in corticobasal degeneration, Arch Neurol., 55, 957–961, 1998.
44. Monza, D. et al., Neurophysiological features in relation to clinical signs in clinically diagnosed corticobasal degeneration, Neurol. Sci., 24(1), 16–23, 2003.
45. Salazar, G. et al., Postural and action myoclonus in patients with parkinsonian type multiple system atrophy, Movement Disorders, 15(1), 77–83, 2000.
46. Tanigawa, A., Komiyama, A., and Hasegawa, O., Truncal muscle tonus in progressive supranuclear palsy, J. Neurol. Neurosurg. Psychiatry, 64(2), 190–196, 1998.
47. Lang, A. E., Parkinsonism in corticobasal degeneration, Advances in Neurology, 82, 83–89, 2000.
48. Giladi, N., Gait disturbances in advanced stages of Parkinson’s disease, Adv. Neurol., 86, 273–278, 2001.
49. Kyriakides, T. and Hewer, R. L., Hand contractures in Parkinson’s disease, J. Neurol. Neurosurg. Psychiatry, 51(9), 1221–1223, 1988.
50. Uhrin, Z. and Stein, H., Rheumatoid-like deformities in Parkinson’s disease, Journal of Rheumatology, 25(1), 177–179, 1998.
51. Schabitz, W. R. et al., Severe forward flexion of the trunk in Parkinson’s disease: Focal myopathy of the paraspinal muscles mimicking camptocormia, Mov. Disord., 18(4), 408–414. 2003.
52. Barclay, C. L. and Lang, A. E., Dystonia in progressive supranuclear palsy, J. Neurol. Neurosurg. Psychiatry, 62(4), 352–356, 1997.
53. Askmark, H. et al., Parkinsonism and neck extensor myopathy—A new syndrome or coincidental findings? Archives of Neurology, 58(2), 232–237, 2001.
54. Munhoz, R. P. et al., Evaluation of the pull test technique in assessing postural instability in Parkinson’s disease, Neurology, 2003 (in press).
55. Wenning, G. K. et al., Cerebellar presentation of multiple system atrophy, Movement Disorders, 12(1), 115–117, 1997.
56. Kuba, H. et al., Gait disturbance in patients with low pressure hydrocephalus, J. Clin. Neurosci., 9(1), 33–36, 2002.
57. Demirkiran, M., Bozdemir, H., and Sarica, Y., Vascular parkinsonism: A distinct, heterogeneous clinical entity, Acta Neurol. Scand., 104(2), 63–67, 2001.
58. Winkler, A. S. et al., The frequency and significance of “striatal toe” in parkinsonism, Parkinsonism Relat. Disord., 9(2), 97–101, 2002.
59. Schrag, A. et al., Young-onset Parkinson’s disease revisited—clinical features, natural history, and mortality, Mov Disord., 1998, 13(6), 885–894, 1998.
60. Caviness, J. N. et al., Cortical myoclonus in levodoparesponsive parkinsonism, Movement Disorders, 13(3), 540–544, 1998.
61. Louis, E. D. et al., Comparison of extrapyramidal features in 31 pathologically confirmed cases of diffuse Lewy body disease and 34 pathologically confirmed cases of Parkinson’s disease, Neurology, 48(2), 376–380, 1997.
62. Aarsland, D. et al., Prevalence and characteristics of dementia in Parkinson disease—An 8-year prospective study, Archives of Neurology, 60(3), 387–392, 2003.
63. Dubois, B. et al., Slowing of cognitive processing in progressive supranuclear palsy. A comparison with Parkinson’s disease, Archives of Neurology, 45(11), 1194–1199, 1988.
64. Lossos, A. et al., Frontotemporal dementia and parkinsonism with the P301S tau gene mutation in a Jewish family, J. Neurol., 250(6), 733–740, 2003.
65. Pillon, B. et al., The neuropsychological pattern of corticobasal degeneration: Comparison with progressive supranuclear palsy and Alzheimer’s disease, Neurology, 45, 1477–1483, 1995.
66. Dubois, B. et al., The FAB—A frontal assessment battery at bedside, Neurology, 55(11), 1621–1626, 2000.
67. Valls-Sole, J. et al., Distinctive abnormalities of facial reflexes in patients with progressive supranuclear palsy, Brain, 120 (Pt. 10), 1877–1883, 1997.
68. McKeith, I. G., Dementia with Lewy bodies, Br. J. Psychiatry, 180, 144–147, 2002.
69. McKeith, I. et al., Neuroleptic sensitivity in patients with senile dementia of Lewy body type, British Medical Journal, 305, 673–678, 1992.
70. Barclay, C. L., Bergeron, C. and Lang, A. E., Arm levitation in progressive supranuclear palsy, Neurology, 52(4), 879–882, 1999.
71. Louis, E. D. et al., Arm elevation in Huntington’s disease: Dystonia or levitation? Movement Disorders, 14(6), 1035–1038, 1999.
72. Snider, S. R. et al., Primary sensory symptoms in parkinsonism, Neurology, 26(5), 423–429, 1976.
73. Wenning, G. K. et al., Clinicopathological study of 35 cases of multiple system atrophy, J. Neurol. Neurosurg. Psychiatry, 58(2), 160–166, 1995.
74. Wenning, G. K. et al., Multiple system atrophy: A review of 203 pathologically proven cases, Mov. Disord., 12(2), 133–147, 1997.
75. Klein, C. et al., The “cold hands sign” in multiple system atrophy, Mov. Disord., 12(4), 514–518, 1997.
76. Jost, W. H. and Schimrigk, K., Constipation in Parkinson’s disease, Klin. Wochenschr., 69(20), 906–909, 1991.
77. Siddiqui, M. F. et al., Autonomic dysfunction in Parkinson’s disease: A comprehensive symptom survey, Parkinsonism Relat. Disord., 8(4), 277–284, 2002.
78. Horimoto, Y. et al., Autonomic dysfunctions in dementia with Lewy bodies, J. Neurol., 250(5), 530–533, 2003.
79. Olson, E. J., Boeve, B. F., and Silber, M. H., Rapid eye movement sleep behaviour disorder: Demographic, clinical and laboratory findings in 93 cases, Brain, 123(2), 331–339, 2000.
80. Arnulf, I. et al., Hallucinations, REM sleep, and Parkinson’s disease—A medical hypothesis, Neurology, 55(2), 281–288, 2000.
81. Boeve, B. F. et al., REM sleep behavior disorder and degenerative dementia—An association likely reflecting Lewy body disease, Neurology, 51(2), 363–370, 1998.
82. Friedman, J. H., Presumed rapid eye movement behavior disorder in Machado-Joseph disease (spinocerebellar ataxia type 3), Movement Disorders, 17(6), 1350–1353, 2002.
83. Krishnan, P. R., Bhatia, M., and Behari, M., Restless legs syndrome in Parkinson’s disease: A case-controlled study, Movement Disorders, 18(2), 181–185, 2003.
84. Wetter, T. C. et al., Sleep and periodic leg movement patterns in drug-free patients with Parkinson’s disease and multiple system atrophy, Sleep, 23(3), 361–367, 2000.
85. Factor, S. A. et al., Sleep disorders and sleep effect in Parkinson’s disease, Mov. Disord., 5(4), 280–285, 1990.
86. Gjerstad, M. D., Aarsland, D., and Larsen, J. P., Development of daytime somnolence over time in Parkinson’s disease, Neurology, 58(10), 1544–1546, 2002.
87. Frucht, S. et al., Falling asleep at the wheel: Motor vehicle mishaps in persons taking pramipexole and ropinirole, Neurology, 52(9), 1908–1910, 1999.
88. Schlesinger, I. and Ravin, P. D., Dopamine agonists induce episodes of irresistible daytime sleepiness, European Neurology, 49(1), 30–33, 2003.
89. Pal, S. et al., A study of excessive daytime sleepiness and its clinical significance in three groups of Parkinson’s disease patients taking pramipexole, cabergoline and levodopa mono and combination therapy, Journal of Neural Transmission, 108(1), 71–77, 2001.
90. Boesch, S. M. et al., Dystonia in multiple system atrophy, J. Neurol. Neurosurg. Psychiatry, 72(3), 300–303, 2002.
91. Litvan, I. and Hutton, M., Clinical and genetic aspects of progressive supranuclear palsy, J. Geriatr. Psychiatry Neurol., 11(2), 107–114, 1998.
92. Hely, M. A. et al., Diffuse Lewy body disease: Clinical features in nine cases without coexistent Alzheimer’s disease, J. Neurol. Neurosurg. Psychiatry, 60(5), 531–538, 1996.
93. Nutt, J. G. and Nygaard, T. G., Response to levodopa treatment in dopa-responsive dystonia, Archives of Neurology, 58(6), 905–910, 2001.
94. Ben-Shlomo, Y. et al., Survival of patients with pathologically proven multiple system atrophy: A meta-analysis, Neurology, 48(2), 384–393, 1997.